These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1354 related items for PubMed ID: 15154858

  • 1. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
    Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB.
    Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
    [Abstract] [Full Text] [Related]

  • 2. Similarities and differences between chronic migraine and episodic migraine.
    Ferrari A, Leone S, Vergoni AV, Bertolini A, Sances G, Coccia CP, Ottani A, Pinetti D, Sternieri E.
    Headache; 2007 Jan; 47(1):65-72. PubMed ID: 17355496
    [Abstract] [Full Text] [Related]

  • 3. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period.
    Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME.
    Headache; 2006 May; 46(5):766-72. PubMed ID: 16643579
    [Abstract] [Full Text] [Related]

  • 4. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study.
    Wang SJ, Fuh JL, Lu SR, Juang KD.
    Neurology; 2007 Feb 20; 68(8):591-6. PubMed ID: 17182975
    [Abstract] [Full Text] [Related]

  • 5. Migraine days decline with duration of illness in adolescents with transformed migraine.
    Bigal ME, Sheftell FD, Tepper SJ, Rapoport AM, Lipton RB.
    Cephalalgia; 2005 Jul 20; 25(7):482-7. PubMed ID: 15955034
    [Abstract] [Full Text] [Related]

  • 6. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up.
    Grazzi L, Andrasik F, D'Amico D, Usai S, Kass S, Bussone G.
    Headache; 2004 Jul 20; 44(7):678-83. PubMed ID: 15209690
    [Abstract] [Full Text] [Related]

  • 7. Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study.
    Scher AI, Lipton RB, Stewart WF, Bigal M.
    Cephalalgia; 2010 Mar 20; 30(3):321-8. PubMed ID: 19614708
    [Abstract] [Full Text] [Related]

  • 8. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs.
    Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G.
    Cephalalgia; 2006 Sep 20; 26(9):1097-105. PubMed ID: 16919060
    [Abstract] [Full Text] [Related]

  • 9. Chronic daily headache in adolescents: prevalence, impact, and medication overuse.
    Wang SJ, Fuh JL, Lu SR, Juang KD.
    Neurology; 2006 Jan 24; 66(2):193-7. PubMed ID: 16434652
    [Abstract] [Full Text] [Related]

  • 10. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up.
    Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z, Pavlovic A, Mijajlovic M, Radojicic A, Sternic N.
    Cephalalgia; 2007 Nov 24; 27(11):1219-25. PubMed ID: 17888081
    [Abstract] [Full Text] [Related]

  • 11. Medication overuse headache.
    Ward TN.
    Prim Care; 2004 Jun 24; 31(2):369-80, vii. PubMed ID: 15172512
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP, Cady RK.
    Clin Ther; 2007 Jun 24; 29 Suppl():2511-9. PubMed ID: 18164918
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr 24; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 14. The classification of chronic daily headache in adolescents--a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria.
    Bigal ME, Rapoport AM, Tepper SJ, Sheftell FD, Lipton RB.
    Headache; 2005 May 24; 45(5):582-9. PubMed ID: 15953277
    [Abstract] [Full Text] [Related]

  • 15. Out-patient detoxification in chronic migraine: comparison of strategies.
    Krymchantowski AV, Moreira PF.
    Cephalalgia; 2003 Dec 24; 23(10):982-93. PubMed ID: 14984232
    [Abstract] [Full Text] [Related]

  • 16. Chronic migraine: current concepts and ongoing treatments.
    Negro A, Rocchietti-March M, Fiorillo M, Martelletti P.
    Eur Rev Med Pharmacol Sci; 2011 Dec 24; 15(12):1401-20. PubMed ID: 22288302
    [Abstract] [Full Text] [Related]

  • 17. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study.
    Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V.
    Cephalalgia; 2005 Jan 24; 25(1):12-5. PubMed ID: 15606564
    [Abstract] [Full Text] [Related]

  • 18. Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache.
    Trucco M, Meineri P, Ruiz L, "Gruppo Neurologico Ospedaliero Interregionale per lo Studio delle Cefalee" (Neurological Hospital Interregional Group for the Study of Headache).
    J Headache Pain; 2005 Sep 24; 6(4):334-7. PubMed ID: 16362704
    [Abstract] [Full Text] [Related]

  • 19. Medication-overuse headache.
    Tepper SJ.
    Continuum (Minneap Minn); 2012 Aug 24; 18(4):807-22. PubMed ID: 22868543
    [Abstract] [Full Text] [Related]

  • 20. Chronic daily headache in adolescents: an 8-year follow-up study.
    Wang SJ, Fuh JL, Lu SR.
    Neurology; 2009 Aug 11; 73(6):416-22. PubMed ID: 19605771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.